Elixabet
Bolaños Mateo
Investigadora Colaboradora
Sara
Labiano Almiñana
Investigadora
Publicacions en què col·labora amb Sara Labiano Almiñana (11)
2019
-
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Cancer cell, Vol. 36, Núm. 6, pp. 613-629
2018
-
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
OncoImmunology, Vol. 7, Núm. 1
-
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated t-cell cross-priming
Cancer Research, Vol. 78, Núm. 23, pp. 6643-6654
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2017
-
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
OncoImmunology, Vol. 6, Núm. 4
2016
-
Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
Cancer Research, Vol. 76, Núm. 20, pp. 5994-6005
-
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
European Journal of Immunology, Vol. 46, Núm. 3, pp. 513-522
-
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
OncoImmunology, Vol. 5, Núm. 1
2015
-
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 24, pp. 7551-7556
-
Virotherapy with a Semliki forest virus-based vector encoding IL12 synergizes with PD-1/PD-L1 blockade
Cancer Immunology Research, Vol. 3, Núm. 5, pp. 449-454
2013
-
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Clinical Cancer Research, Vol. 19, Núm. 22, pp. 6151-6162